You have 9 free searches left this month | for more free features.

lobular breast carcinoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lobular Breast Carcinoma Trial in Monaco (68Ga-FAPI-46 PET scan)

Not yet recruiting
  • Lobular Breast Carcinoma
  • 68Ga-FAPI-46 PET scan
  • Monaco, Monaco
    Centre Hospitalier Princesse Grace
Jun 27, 2023

Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)

Not yet recruiting
  • Metastatic Breast Cancer
  • Lobular Breast Carcinoma
  • Blood Specimen
  • San Francisco, California
    University of California, San Francisco
Jul 19, 2023

Pure Florid and Pleomorphic Lobular Carcinoma in Situ of Breast:

Recruiting
  • Pleomorphic Lobular Breast Carcinoma in Situ
  • Breast Florid Lobular Carcinoma in Situ
  • Surgical wide local excision
  • +4 more
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Nov 14, 2023

Breast Cancer Female, Lobular Breast Carcinoma, PET/MRI Trial (drug, procedure, genetic)

Not yet recruiting
  • Breast Cancer Female
  • +4 more
  • (no location specified)
Aug 8, 2023

Searching for Novel Germline Mutations in Lobular Breast Cancer

Recruiting
  • Lobular Breast Carcinoma
  • +3 more
  • Illumina panel
  • Milan, Italy
    European Institute of Oncology
Sep 12, 2022

Invasive Lobular Breast Carcinoma Trial in Salt Lake City ([18F]Fluoroestradiol (FES) PET/CT)

Recruiting
  • Invasive Lobular Breast Carcinoma
  • [18F]Fluoroestradiol (FES) PET/CT
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 14, 2022

Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation

Active, not recruiting
  • Breast Cancer
  • +4 more
  • External Beam Radiation Therapy
  • +2 more
  • Richmond, Virginia
  • +1 more
Dec 16, 2022

CDH1 Germline Mutations in Lobular Breast Cancer

Active, not recruiting
  • Lobular Breast Carcinoma
  • CDH1 Gene Inactivation
    • Milan, Italy
      European Institute of Oncology
    Jan 11, 2022

    Carcinoma, Lobular Trial ([18F]fluoroestradiol (FES))

    Not yet recruiting
    • Carcinoma, Lobular
    • [18F]fluoroestradiol (FES)
    • (no location specified)
    Jul 18, 2023

    Invasive Lobular Breast Carcinoma, ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Belgium, France (Entrectinib,

    Recruiting
    • Invasive Lobular Breast Carcinoma
    • +2 more
    • Brussels, Belgium
    • +9 more
    May 4, 2022

    Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States

    Recruiting
    • Invasive Ductal Breast Carcinoma
    • +14 more
    • Stereotactic body radiotherapy
    • Lattice Radiation Therapy
    • Basking Ridge, New Jersey
    • +6 more
    Apr 20, 2023

    Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer Trial in United States

    Not yet recruiting
    • Anatomic Stage I Breast Cancer
    • +3 more
    • Endocrine Therapy
    • +7 more
    • Atlanta, Georgia
    • +4 more
    Jun 15, 2023

    Treating Patients With Stage IV Breast Cancer

    Active, not recruiting
    • Central Nervous System Metastases
    • +15 more
    • hyperfractionated radiation therapy
    • +2 more
    • North Chicago, Illinois
      University of Chicago
    Dec 6, 2021

    Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

    Recruiting
    • Atypical Hyperplasia
    • Lobular Carcinoma in Situ
    • Evanston, Illinois
    • +1 more
    Jan 20, 2023

    Standard Breast Cancer Risk Assessment for African American and

    Not yet recruiting
    • Breast Atypical Ductal Hyperplasia
    • +3 more
    • Biospecimen Collection
    • +2 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Feb 22, 2023

    Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston

    Completed
    • Breast Atypical Ductal Hyperplasia
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 13, 2022

    Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

    Not yet recruiting
    • Breast Atypical Hyperplasia
    • +3 more
    • Acolbifene Hydrochloride
    • +4 more
    • Duarte, California
    • +3 more
    Jul 11, 2023

    BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

    Not yet recruiting
    • BRCA Mutation
    • +3 more
    • Tamoxifen 10 Mg Tablet
    • +2 more
    • Genoa, Italy
    • +3 more
    Sep 11, 2023

    Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt

    Active, not recruiting
    • Inflammatory Breast Cancer
    • +9 more
    • External beam radiation therapy
    • New Brunswick, New Jersey
    • +1 more
    Jan 30, 2022

    Breast Cancer Female, Stage I Breast Cancer, Stage II Breast Cancer Trial in Austin (Breast reconstruction decision aid,

    Completed
    • Breast Cancer Female
    • +6 more
    • Breast reconstruction decision aid
    • Educational website
    • Austin, Texas
      Texas Oncology
    Nov 1, 2021

    Molecular Analysis of the Sloane Project

    Enrolling by invitation
    • DCIS
    • +3 more
      • London, United Kingdom
        King's College London
      May 11, 2023

      Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ Trial in

      Recruiting
      • Atypical Hyperplasia of the Breast
      • +2 more
      • Cancer Educational Materials
      • +3 more
      • Costa Mesa, California
      • +48 more
      Jan 9, 2023

      Lobular Breast Carcinoma, Gastric Cancer, Triple Negative Breast Cancer Trial in United Kingdom (Crizotinib Oral Capsule

      Recruiting
      • Lobular Breast Carcinoma
      • +3 more
      • Crizotinib Oral Capsule [Xalkori]
      • Fulvestrant 50 MG/ML Prefilled Syringe [Faslodex or generic]
      • Glasgow, United Kingdom
      • +7 more
      Nov 1, 2021

      Benign Breast Tumor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Boston, New York, Houston

      Completed
      • Benign Breast Neoplasm
      • +11 more
      • Docosahexaenoic Acid
      • Placebo
      • Boston, Massachusetts
      • +3 more
      Dec 3, 2021